Spider venoms: a rich source of acylpolyamines and peptides as new leads for CNS drugs.

Advances in NMR and mass spectrometry as well as in peptide biochemistry coupled to modern methods in electrophysiology have permitted the isolation and identification of numerous products from spider venoms, previously explored due to technical limitations. The chemical composition of spider venoms is diverse, ranging from low molecular weight organic compounds such as acylpolyamines to complex peptides. First, acylpolyamines (< 1000 Da) have an aromatic moiety linked to a hydrophilic lateral chain. They were characterized for the first time in spider venoms and are ligand-gated ion channel antagonists, which block mainly postsynaptic glutamate receptors in invertebrate and vertebrate nervous systems. Acylpolyamines represent the vast majority of organic components from the spider venom. Acylpolyamine analogues have proven to suppress hippocampal epileptic discharges. Moreover, acylpolyamines could suppress excitatory postsynaptic currents inducing Ca+ accumulation in neurons leading to protection against a brain ischemic insult. Second, short spider peptides (< 6000 Da) modulate ionic currents in Ca2+, Na+, or K+ voltage-gated ion channels. Such peptides may contain from three to four disulfide bridges. Some spider peptides act specifically to discriminate among Ca2+, Na+, or K+ ion channel subtypes. Their selective affinities for ion channel subfamilies are functional for mapping excitable cells. Furthermore, several of these peptides have proven to hyperpolarize peripheral neurons, which are associated with supplying sensation to the skin and skeletal muscles. Some spider N-type calcium ion channel blockers may be important for the treatment of chronic pain. A special group of spider peptides are the amphipathic and positively charged peptides. Their secondary structure is alpha-helical and they insert into the lipid cell membrane of eukaryotic or prokaryotic cells leading to the formation of pores and subsequently depolarizing the cell membrane. Acylpolyamines and peptides from spider venoms represent an interesting source of molecules for the design of novel pharmaceutical drugs.

[1]  M. Romano-Silva,et al.  Neuroprotective effect on brain injury by neurotoxins from the spider Phoneutria nigriventer , 2006, Neurochemistry International.

[2]  E. Grishin,et al.  Latarcins, Antimicrobial and Cytolytic Peptides from the Venom of the Spider Lachesana tarabaevi (Zodariidae) That Exemplify Biomolecular Diversity* , 2006, Journal of Biological Chemistry.

[3]  G. Alcaraz,et al.  Phoneutria nigriventer Toxin 1: A Novel, State-Dependent Inhibitor of Neuronal Sodium Channels That Interacts with μ Conotoxin Binding Sites , 2006, Molecular Pharmacology.

[4]  P. Escoubas Mass spectrometry in toxinology: a 21st-century technology for the study of biopolymers from venoms. , 2006, Toxicon : official journal of the International Society on Toxinology.

[5]  G. King,et al.  Venom landscapes: mining the complexity of spider venoms via a combined cDNA and mass spectrometric approach. , 2006, Toxicon : official journal of the International Society on Toxinology.

[6]  Y. Mori,et al.  Phoneutria nigriventer ω-Phonetoxin IIA: A new tool for anti-calcium channel autoantibody assays in Lambert–Eaton myasthenic syndrome , 2006, Neurobiology of Disease.

[7]  J. Dai,et al.  Function and Solution Structure of Huwentoxin-X, a Specific Blocker of N-type Calcium Channels, from the Chinese Bird Spider Ornithoctonus huwena* , 2006, Journal of Biological Chemistry.

[8]  J. McGivern Targeting N-type and T-type calcium channels for the treatment of pain. , 2006, Drug discovery today.

[9]  D. Giuliani,et al.  Involvement of glutamate receptors of the NMDA type in the modulation of acetylcholine and glutamate overflow from the guinea pig ileum during in vitro hypoxia and hypoglycaemia , 2006, Neurochemistry International.

[10]  D. Muller,et al.  Glutamate receptor changes associated with transient anoxia/hypoglycaemia in hippocampal slice cultures , 2006, The European journal of neuroscience.

[11]  K. Gogas Glutamate-based therapeutic approaches: NR2B receptor antagonists. , 2006, Current opinion in pharmacology.

[12]  M. Lazdunski,et al.  Four Novel Tarantula Toxins as Selective Modulators of Voltage-Gated Sodium Channel Subtypes , 2006, Molecular Pharmacology.

[13]  D. Jane,et al.  The glutamate story , 2006, British journal of pharmacology.

[14]  K. Swartz,et al.  An inhibitor of TRPV1 channels isolated from funnel Web spider venom. , 2005, Biochemistry.

[15]  E. Grishin,et al.  Classification of spider neurotoxins using structural motifs by primary structure features. Single residue distribution analysis and pattern analysis techniques. , 2005, Toxicon : official journal of the International Society on Toxinology.

[16]  C. Kushmerick,et al.  Inhibition of High Voltage-Activated Calcium Channels by Spider Toxin PnTx3-6 , 2005, Journal of Pharmacology and Experimental Therapeutics.

[17]  N. Seiler Pharmacological aspects of cytotoxic polyamine analogs and derivatives for cancer therapy. , 2005, Pharmacology & therapeutics.

[18]  Gerald W Zamponi,et al.  Voltage gated calcium channels as targets for analgesics. , 2005, Current topics in medicinal chemistry.

[19]  J. Tytgat,et al.  Jingzhaotoxin-I, a Novel Spider Neurotoxin Preferentially Inhibiting Cardiac Sodium Channel Inactivation* , 2005, Journal of Biological Chemistry.

[20]  E. Villegas,et al.  A Spider Toxin That Induces a Typical Effect of Scorpion α-Toxins but Competes with β-Toxins on Binding to Insect Sodium Channels† , 2005 .

[21]  S. Diochot Precious Natural Peptides from Spider Venoms: New Tools for Studying Potassium Channels , 2005 .

[22]  H. Darbon,et al.  An Overview of The Three Dimensional Structure of Short Spider Toxins , 2005 .

[23]  E. Villegas,et al.  Pore-Forming Peptides from Spiders , 2005 .

[24]  N. Kawai Spider Polyamine Toxin , 2005 .

[25]  A Schurr,et al.  Neuroprotection against ischemic/hypoxic brain damage: blockers of ionotropic glutamate receptor and voltage sensitive calcium channels. , 2004, Current drug targets.

[26]  X. Gu,et al.  Structure-Activity Relationships of Hainantoxin-IV and Structure Determination of Active and Inactive Sodium Channel Blockers* , 2004, Journal of Biological Chemistry.

[27]  E. Andrès,et al.  Peptides antimicrobiens cationiques : de l'étude de l'immunité innée à la production de médicaments , 2004 .

[28]  R. MacKinnon,et al.  A membrane-access mechanism of ion channel inhibition by voltage sensor toxins from spider venom , 2004, Nature.

[29]  Arunmozhiarasi Armugam,et al.  Toxins in anti-nociception and anti-inflammation. , 2004, Toxicon : official journal of the International Society on Toxinology.

[30]  L. Sorkin,et al.  Calcium-Permeable α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/Kainate Receptors Mediate Development, but Not Maintenance, of Secondary Allodynia Evoked by First-Degree Burn in the Rat , 2004, Journal of Pharmacology and Experimental Therapeutics.

[31]  Yucheng Xiao,et al.  Jingzhaotoxin-III, a Novel Spider Toxin Inhibiting Activation of Voltage-gated Sodium Channel in Rat Cardiac Myocytes* , 2004, Journal of Biological Chemistry.

[32]  O. Pongs,et al.  Modulation of Kv4.2 channels by a peptide isolated from the venom of the giant bird-eating tarantula Theraphosa leblondi. , 2004, Toxicon : official journal of the International Society on Toxinology.

[33]  P. Escoubas,et al.  Tarantulas: eight-legged pharmacists and combinatorial chemists. , 2004, Toxicon : official journal of the International Society on Toxinology.

[34]  H. Naoki,et al.  Study on the Structure Activity Relationships of NPTX-594, a Spider Toxin Belonging to the Type-B Acylpolyamine Structure , 2004 .

[35]  J. Olsen,et al.  De novo sequencing of antimicrobial peptides isolated from the venom glands of the wolf spider Lycosa singoriensis. , 2004, Journal of mass spectrometry : JMS.

[36]  T. Narahashi,et al.  Modification of sodium channel gating and kinetics by versutoxin from the Australian funnel-web spiderHadronyche versuta , 1994, Pflügers Archiv.

[37]  J. L. Raszkiewicz,et al.  Design, Synthesis, and Biological Evaluation of Spider Toxin (Argiotoxin-636) Analogs as NMDA Receptor Antagonists , 2004, Pharmaceutical Research.

[38]  M. Adams,et al.  Two classes of channel-specific toxins from funnel web spider venom , 2004, Journal of Comparative Physiology A.

[39]  L. Kuhn-Nentwig Antimicrobial and cytolytic peptides of venomous arthropods , 2003, Cellular and Molecular Life Sciences CMLS.

[40]  D. Sukumaran,et al.  Susceptibility of oral bacteria to an antimicrobial decapeptide. , 2003, Journal of medical microbiology.

[41]  P. Escoubas,et al.  Pharmacologically active spider peptide toxins , 2003, Cellular and Molecular Life Sciences CMLS.

[42]  E. Villegas,et al.  The hemolytic activity of six arachnid cationic peptides is affected by the phosphatidylcholine-to-sphingomyelin ratio in lipid bilayers. , 2003, Biochimica et biophysica acta.

[43]  T. Brennan,et al.  Spinal glutamate receptor antagonists differentiate primary and secondary mechanical hyperalgesia caused by incision , 2003, Pain.

[44]  J. Łukasiak,et al.  Prophylactic Efficacy of Topical Temporin A and RNAIII-Inhibiting Peptide in a Subcutaneous Rat Pouch Model of Graft Infection Attributable to Staphylococci With Intermediate Resistance to Glycopeptides , 2003, Circulation.

[45]  L. Sundstrom,et al.  Characterisation of a novel class of polyamine-based neuroprotective compounds , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

[46]  J. Haupt,et al.  Distinct primary structures of the major peptide toxins from the venom of the spider Macrothele gigas that bind to sites 3 and 4 in the sodium channel1 , 2003, FEBS letters.

[47]  T. Shinada,et al.  Synthesis and paralytic activities of squaryl amino acid-containing polyamine toxins , 2003, Amino Acids.

[48]  D. Barra,et al.  An amphibian antimicrobial peptide variant expressed in Nicotiana tabacum confers resistance to phytopathogens. , 2003, The Biochemical journal.

[49]  P. Calabresi,et al.  Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? insights from in vitro studies , 2003, Neurobiology of Disease.

[50]  H. Ulvatne Antimicrobial Peptides , 2003, American journal of clinical dermatology.

[51]  S. Liang,et al.  Function and Solution Structure of Huwentoxin-IV, a Potent Neuronal Tetrodotoxin (TTX)-sensitive Sodium Channel Antagonist from Chinese Bird Spider Selenocosmia huwena * , 2002, The Journal of Biological Chemistry.

[52]  L. Sundstrom,et al.  L‐Arginyl‐3,4‐Spermidine is neuroprotective in several in vitro models of neurodegeneration and in vivo ischaemia without suppressing synaptic transmission , 2002, British journal of pharmacology.

[53]  V. Garsky,et al.  Two tarantula peptides inhibit activation of multiple sodium channels. , 2002, Biochemistry.

[54]  W. Nentwig,et al.  Cupiennin 1d*: the cytolytic activity depends on the hydrophobic N‐terminus and is modulated by the polar C‐terminus , 2002, FEBS letters.

[55]  G. Yellen The voltage-gated potassium channels and their relatives , 2002, Nature.

[56]  I. Shimada,et al.  Solution Structure of ω-Grammotoxin SIA, A Gating Modifier of P/Q and N-type Ca2+ Channel , 2002 .

[57]  E. Villegas,et al.  Oxyopinins, Large Amphipathic Peptides Isolated from the Venom of the Wolf Spider Oxyopes kitabensis with Cytolytic Properties and Positive Insecticidal Cooperativity with Spider Neurotoxins* , 2002, The Journal of Biological Chemistry.

[58]  Y. Mori,et al.  Phoneutria nigriventer ω-Phonetoxin IIA Blocks the Cav2 Family of Calcium Channels and Interacts with ω-Conotoxin-binding Sites* , 2002, Journal of Biological Chemistry.

[59]  J. Molkentin,et al.  Reduction of Ito Causes Hypertrophy in Neonatal Rat Ventricular Myocytes , 2002 .

[60]  P. Escoubas,et al.  Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and high-performance liquid chromatography study of quantitative and qualitative variation in tarantula spider venoms. , 2002, Rapid communications in mass spectrometry : RCM.

[61]  S. Daffre,et al.  The solution structure of gomesin, an antimicrobial cysteine-rich peptide from the spider. , 2002, European journal of biochemistry.

[62]  T. Yamane,et al.  An efficient and versatile synthesis of acylpolyamine spider toxins. , 2002, Bioorganic & medicinal chemistry letters.

[63]  G. King,et al.  STRUCTURE AND FUNCTION OF INSECTICIDAL NEUROTOXINS FROM AUSTRALIAN FUNNEL-WEB SPIDERS , 2002 .

[64]  S. Dib-Hajj,et al.  Diverse functions and dynamic expression of neuronal sodium channels. , 2002, Novartis Foundation symposium.

[65]  P. Krogsgaard‐Larsen,et al.  Recent advances in the medicinal chemistry of polyamine toxins. , 2001, Mini reviews in medicinal chemistry.

[66]  L. Sorkin,et al.  Pain Models Display Differential Sensitivity to Ca2+-Permeable Non-NMDA Glutamate Receptor Antagonists , 2001, Anesthesiology.

[67]  Richard M. Eglen,et al.  Regulation of Na+ channel distribution in the nervous system , 2001, Trends in Neurosciences.

[68]  G. Dayanithi,et al.  Interaction of SNX482 with Domains III and IV Inhibits Activation Gating of α1E (CaV2.3) Calcium Channels , 2001 .

[69]  N. Atkinson,et al.  Evolution and divergence of sodium channel genes in vertebrates , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[70]  H. Saegusa,et al.  Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N‐type Ca2+ channel , 2001, The EMBO journal.

[71]  B. Martinac Mechanosensitive Channels in Prokaryotes , 2001, Cellular Physiology and Biochemistry.

[72]  S. Liang,et al.  The effect of Huwentoxin-I on Ca(2+) channels in differentiated NG108-15 cells, a patch-clamp study. , 2001, Toxicon : official journal of the International Society on Toxinology.

[73]  F. Sachs,et al.  Tarantula peptide inhibits atrial fibrillation , 2001, Nature.

[74]  O. Pongs,et al.  Solution structure of hpTX2, a toxin from Heteropoda venatoria spider that blocks Kv4.2 potassium channel. , 2001, Protein science : a publication of the Protein Society.

[75]  J. Sullivan,et al.  Potassium channels: molecular defects, diseases, and therapeutic opportunities. , 2000, Pharmacological reviews.

[76]  W. Robberecht,et al.  Different receptors mediate motor neuron death induced by short and long exposures to excitotoxicity , 2000, Brain Research Bulletin.

[77]  W. Catterall,et al.  Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. , 2000, Biochimie.

[78]  P. Escoubas,et al.  Structure and pharmacology of spider venom neurotoxins. , 2000, Biochimie.

[79]  M. Stankiewicz,et al.  Isolation, synthesis and pharmacological characterization of delta-palutoxins IT, novel insecticidal toxins from the spider Paracoelotes luctuosus (Amaurobiidae). , 2000, European journal of biochemistry.

[80]  Alain Lecoq,et al.  Isolation of a Tarantula Toxin Specific for a Class of Proton-gated Na+ Channels* , 2000, The Journal of Biological Chemistry.

[81]  Marco A Romano-Silva,et al.  Inhibition of glutamate uptake by Tx3‐4 is dependent on the redox state of cysteine residues , 2000, Neuroreport.

[82]  D. Hall,et al.  Solid phase syntheses of polyamine toxins HO-416b and PhTX-433. Use of an efficient polyamide reduction strategy that facilitates access to branched analogues. , 2000, Organic letters.

[83]  K. Swartz,et al.  Localization and Molecular Determinants of the Hanatoxin Receptors on the Voltage-Sensing Domains of a K+ Channel , 2000, The Journal of general physiology.

[84]  F. Sachs,et al.  Identification of a Peptide Toxin from Grammostola spatulata Spider Venom That Blocks Cation-Selective Stretch-Activated Channels , 2000, The Journal of general physiology.

[85]  I. Shimada,et al.  Solution structure of hanatoxin1, a gating modifier of voltage-dependent K(+) channels: common surface features of gating modifier toxins. , 2000, Journal of molecular biology.

[86]  W. Nentwig,et al.  Characterisation of antibacterial activity of peptides isolated from the venom of the spider Cupiennius salei (Araneae: Ctenidae). , 2000, Toxicon : official journal of the International Society on Toxinology.

[87]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[88]  E. Mccleskey,et al.  Ion channels of nociception. , 2020, Annual review of physiology.

[89]  L. Sorkin,et al.  Mechanical allodynia in rats is blocked by a Ca2+ permeable AMPA receptor antagonist. , 1999, Neuroreport.

[90]  Inhibition of glutamate uptake by a polypeptide toxin (phoneutriatoxin 3-4) from the spider Phoneutria nigriventer. , 1999, The Biochemical journal.

[91]  E. Grishin Polypeptide neurotoxins from spider venoms. , 1999, European journal of biochemistry.

[92]  C. Diniz,et al.  PhTx4, a new class of toxins from Phoneutria nigriventer spider venom, inhibits the glutamate uptake in rat brain synaptosomes , 1999, Brain Research.

[93]  R. Norton,et al.  1H NMR study of robustoxin, the lethal neurotoxin from the funnel web spider Atrax robustus. , 1999, Toxicon : official journal of the International Society on Toxinology.

[94]  M. Lazdunski,et al.  Effects of phrixotoxins on the Kv4 family of potassium channels and implications for the role of Ito1 in cardiac electrogenesis , 1999, British journal of pharmacology.

[95]  D. Figlewicz,et al.  Glutamate Potentiates the Toxicity of Mutant Cu/Zn-Superoxide Dismutase in Motor Neurons by Postsynaptic Calcium-Dependent Mechanisms , 1998, The Journal of Neuroscience.

[96]  D. Gordon,et al.  δ‐Atracotoxins from Australian funnel‐web spiders compete with scorpion α‐toxin binding on both rat brain and insect sodium channels , 1998 .

[97]  G. Wang,et al.  Selective peptide antagonist of the class E calcium channel from the venom of the tarantula Hysterocrates gigas. , 1998, Biochemistry.

[98]  M. Miyashita,et al.  Structures of spider toxins: hydroxyindole-3-acetylpolyamines and a new generalized structure of type-E compounds obtained from the venom of the Joro spider, Nephila clavata. , 1998, Toxicon : official journal of the International Society on Toxinology.

[99]  R. Volkmann,et al.  Inhibition of neuronal calcium channels by a novel peptide spider toxin, DW13.3. , 1998, Molecular pharmacology.

[100]  J. Cipolla-Neto,et al.  ω-Phonetoxin-IIA: a calcium channel blocker from the spider Phoneutria nigriventer , 1998, Pflügers Archiv.

[101]  M. Lazdunski,et al.  H+-gated cation channels: neuronal acid sensors in the NaC/DEG family of ion channels , 1998, Current Opinion in Neurobiology.

[102]  L. Suva,et al.  Expression of an N-methyl-D-aspartate-type receptor by human and rat osteoblasts and osteoclasts suggests a novel glutamate signaling pathway in bone. , 1998, Bone.

[103]  E. Cohen,et al.  Cytotoxic effects of arthropod venoms on various cultured cells. , 1998, Toxicon : official journal of the International Society on Toxinology.

[104]  H. Glossmann,et al.  Structural basis of drug binding to L Ca2+ channels. , 1998, Trends in pharmacological sciences.

[105]  F. Metzger,et al.  Effect of Glutamate on Dendritic Growth in Embryonic Rat Motoneurons , 1998, The Journal of Neuroscience.

[106]  M. Adams,et al.  Lycotoxins, Antimicrobial Peptides from Venom of the Wolf SpiderLycosa carolinensis * , 1998, The Journal of Biological Chemistry.

[107]  D. Andreu,et al.  Animal antimicrobial peptides: an overview. , 1998, Biopolymers.

[108]  R. Norton,et al.  Solution structure of robustoxin, the lethal neurotoxin from the funnel‐web spider Atrax robustus , 1997, FEBS letters.

[109]  J. Mackay,et al.  The structure of versutoxin (delta-atracotoxin-Hv1) provides insights into the binding of site 3 neurotoxins to the voltage-gated sodium channel. , 1997, Structure.

[110]  K. Williams Interactions of polyamines with ion channels. , 1997, The Biochemical journal.

[111]  Hughes,et al.  Enhanced Bioactivity of Recombinant Baculoviruses Expressing Insect-Specific Spider Toxins in Lepidopteran Crop Pests , 1997, Journal of invertebrate pathology.

[112]  L. Suva,et al.  Mechanically regulated expression of a neural glutamate transporter in bone: a role for excitatory amino acids as osteotropic agents? , 1997, Bone.

[113]  R. Volkmann,et al.  Heteropodatoxins: peptides isolated from spider venom that block Kv4.2 potassium channels. , 1997, Molecular pharmacology.

[114]  D. Snyders,et al.  Electrophysiological and pharmacological correspondence between Kv4.2 current and rat cardiac transient outward current. , 1997, Cardiovascular research.

[115]  W. Hodgson PHARMACOLOGICAL ACTION OF AUSTRALIAN ANIMAL VENOMS , 1997, Clinical and experimental pharmacology & physiology.

[116]  D. M. Yang,et al.  Blockade of neuromuscular transmission by huwentoxin-I, purified from the venom of the Chinese bird spider Selenocosmia huwena. , 1997, Toxicon : official journal of the International Society on Toxinology.

[117]  J. Warmke,et al.  Properties of Three Baculovirus-Expressing Genes That Encode Insect-Selective Toxins: μ-Aga-IV, As II, and Sh I , 1996 .

[118]  H. Kalbitzer,et al.  Polyamine spider toxins and NMDA receptors: structural basis for channel block and binding of argiotoxin636 , 1996 .

[119]  H. Kalbitzer,et al.  Polyamine spider toxins and mammalian N-methyl-D-aspartate receptors. Structural basis for channel blocking and binding of argiotoxin636. , 1996, European journal of biochemistry.

[120]  A. Macdermott,et al.  Synaptic strengthening through activation of Ca2+ -permeable AMPA receptors , 1996, Nature.

[121]  I. S. Blagbrough,et al.  Differential inhibition of Ca2+ channels in mature rat cerebellar Purkinje cells by sFTX-3.3 and FTX-3.3 , 1996, Neuropharmacology.

[122]  R. MacKinnon,et al.  An inhibitor of the Kv2.1 potassium channel isolated from the venom of a Chilean tarantula , 1995, Neuron.

[123]  J. Fox,et al.  SNX-325, a novel calcium antagonist from the spider Segestria florentina. , 1995, Biochemistry.

[124]  H. Tsubokawa,et al.  Effects of a spider toxin and its analogue on glutamate-activated currents in the hippocampal CA1 neuron after ischemia. , 1995, Journal of neurophysiology.

[125]  H. Robinson,et al.  Single glutamate channels in CA1 pyramidal neurones after transient ischaemia. , 1995, Neuroreport.

[126]  M. Adams,et al.  Neurotoxins: overview of an emerging research technology , 1994, Trends in Neurosciences.

[127]  D. Craik,et al.  A common structural motif incorporating a cystine knot and a triple‐stranded β‐sheet in toxic and inhibitory polypeptides , 1994, Protein science : a publication of the Protein Society.

[128]  K. Valentino,et al.  A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[129]  R. Keith,et al.  Isolation and pharmacological characterization of omega-grammotoxin SIA, a novel peptide inhibitor of neuronal voltage-sensitive calcium channel responses. , 1993, Molecular pharmacology.

[130]  A. Konnerth,et al.  A single amino acid determines the subunit-specific spider toxin block of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor channels. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[131]  C. Diniz,et al.  The purification and amino acid sequences of four Tx2 neurotoxins from the venom of the Brazilian ‘armed’ spider Phoneutria nigriventer (Keys) , 1992, FEBS letters.

[132]  N. Kawai Spider toxin and pertussis toxin differentiate post- and presynaptic glutamate receptors , 1991, Neuroscience Research.

[133]  S. Volrath,et al.  Development of a Recombinant Baculovirus Expressing an Insect-Selective Neurotoxin: Potential for Pest Control , 1991, Bio/Technology.

[134]  H. Robinson,et al.  A voltage-clamp study of the effects of Joro spider toxin and zinc on excitatory synaptic transmission in CA1 pyramidal cells of the guinea pig hippocampal slice , 1991, Neuroscience Research.

[135]  R. Llinás,et al.  Funnel-web spider venom and a toxin fraction block calcium current expressed from rat brain mRNA in Xenopus oocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[136]  G. Kelloff,et al.  Interspecies analysis of the chemopreventive efficacy of dietary alpha-difluoromethylornithine. , 1990, Anticancer research.

[137]  N. Kawai,et al.  Acylpolyamines mimic the action of Joro spider toxin (JSTX) on crustacean muscle glutamate receptors , 1989 .

[138]  G. Collingridge,et al.  Excitatory amino acid receptors in the vertebrate central nervous system. , 1989, Pharmacological reviews.

[139]  R Llinás,et al.  Blocking and isolation of a calcium channel from neurons in mammals and cephalopods utilizing a toxin fraction (FTX) from funnel-web spider poison. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[140]  D. Choi Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage , 1988, Trends in Neurosciences.

[141]  H. Benveniste,et al.  Calcium accumulation by glutamate receptor activation is involved in hippocampal cell damage after ischemia , 1988, Acta neurologica Scandinavica.

[142]  P. Usherwood,et al.  Isolation and characterisation of glutamate receptor antagonists from venoms of orb-web spiders , 1988, Brain Research.

[143]  M. R. Brown,et al.  Amino acid sequence of versutoxin, a lethal neurotoxin from the venom of the funnel-web spider Atrax versutus. , 1988, The Biochemical journal.

[144]  M. Adams,et al.  Structures and biological activities of three synaptic antagonists from orb weaver spider venom. , 1987, Biochemical and biophysical research communications.

[145]  N. Seiler Functions of polyamine acetylation. , 1987, Canadian journal of physiology and pharmacology.

[146]  O. Krishtal,et al.  Spider toxin blocks excitatory amino acid responses in isolated hippocampal pyramidal neurons , 1987, Neuroscience Letters.

[147]  N. Kawai,et al.  Synthesis of a new neurotoxin NSTX-3 of Papua New Guinean spider , 1987 .

[148]  N. Kawai,et al.  Synthesis of spider toxin (JSTX-3) and its analogs , 1987 .

[149]  N. Kawai,et al.  Chemical Characterization of Spider Toxin, JSTX and NSTX , 1986 .

[150]  N. Kawai,et al.  Spider toxin (JSTX) blocks glutamate synapse in hippocampal pyramidal neurons , 1985, Brain Research.

[151]  D. Sheumack,et al.  Complete amino acid sequence of a new type of lethal neurotoxin from the venom of the funnel‐web spider Atrax robustus , 1985, FEBS letters.

[152]  E. Michaelis,et al.  Spider venoms inhibit L-glutamate binding to brain synaptic membrane receptors. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[153]  N. Volkow,et al.  Labeled putrescine as a probe in brain tumors. , 1983, Science.

[154]  N. Kawai,et al.  Spider venom contains specific receptor blocker of glutaminergic synapses , 1982, Brain Research.

[155]  T. Yaksh,et al.  Antinociceptive effects of lanthanum, neodymium and europium following intrathecal administration , 1980, Neuropharmacology.

[156]  P. Pohjanpelto Putrescine transport is greatly increased in human fibroblasts initiated to proliferate , 1976, The Journal of cell biology.

[157]  H. Bohn,et al.  Die Giftsekrete der Vogelspinnen , 1957 .